Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.710
+0.060 (2.26%)
Apr 8, 2026, 10:21 AM EDT - Market open
Genelux Employees
As of December 31, 2025, Genelux had 26 total employees, including 25 full-time and 1 part-time employees. The number of employees increased by 2 or 8.33% compared to the previous year.
Employees
26
Change
2
Growth
8.33%
Revenue / Employee
$308
Profits / Employee
-$1,236,346
Market Cap
120.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 26 | 2 | 8.33% | 25 | 1 |
| Mar 31, 2025 | 24 | 1 | 4.35% | 24 | 0 |
| Dec 31, 2024 | 24 | 1 | 4.35% | 24 | 0 |
| Sep 30, 2024 | 25 | 3 | 13.64% | 25 | 0 |
| Jun 30, 2024 | 24 | 4 | 20.00% | 24 | 0 |
| Mar 31, 2024 | 23 | 8 | 53.33% | 23 | 0 |
| Dec 31, 2023 | 23 | 8 | 53.33% | 23 | 0 |
| Sep 30, 2023 | 22 | 7 | 46.67% | 22 | 0 |
| Jun 30, 2023 | 20 | 6 | 42.86% | 20 | 0 |
| Mar 31, 2023 | 15 | 1 | 7.14% | 15 | 0 |
| Dec 31, 2022 | 15 | 1 | 7.14% | 15 | 0 |
| Sep 30, 2022 | 15 | - | - | 15 | 0 |
| Jun 30, 2022 | 14 | 1 | 7.69% | 14 | 0 |
| Mar 31, 2022 | 14 | 1 | 7.69% | 14 | 0 |
| Mar 31, 2021 | 13 | - | - | 13 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 183 |
| Innate Pharma | 163 |
| Agenus | 81 |
| PepGen | 56 |
| Biomea Fusion | 42 |
| Equillium | 35 |
| Cardiff Oncology | 31 |
| Oncolytics Biotech | 28 |
GNLX News
- 19 days ago - Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 3 months ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 5 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 8 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 9 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire